Dow Up0.25% Nasdaq Up0.65%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.12 Up 0.00(1.75%) May 27, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 39   27   23   47  
Cost of Revenue268  366  353  507  
Gross Profit (229) (339) (330) (460)
Operating Expenses
Research Development1,002  957  1,968  2,439  
Selling General and Administrative2,448  1,547  1,685  2,002  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,679) (2,843) (3,983) (4,901)
Income from Continuing Operations
Total Other Income/Expenses Net1,515  (294)181  56  
Earnings Before Interest And Taxes(2,164)(3,137)(3,802)(4,845)
Interest Expense -   -  1   -  
Income Before Tax(2,164)(3,137)(3,803)(4,845)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,164)(3,137)(3,803)(4,845)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,164) (3,137) (3,803) (4,845)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,164) (3,137) (3,803) (4,845)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.